Stock Events

Stock Events

Solana 

$1.8250
53
-$0.09-4.95% 21:00 Today
-$0.00-0.27%21:17After hours

Statistics

Day High
1.89
Day Low
1.78
52W High
5.47
52W Low
1.185
Volume
761,622
Avg. Volume
504,176
Mkt Cap
118.82M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 10Expected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-435
-290
-145.01
-0.01
Expected EPS
-0.01
Actual EPS
N/A

Financials

-679.57%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
6.02MRevenue
-40.89MNet Income

Analyst Ratings

$4.00Average Price Target
The highest estimate is ⁦4.00⁩.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HSDT. It's not an investment recommendation.
Microsoft
6
MSFT
Tesla
6
TSLA
NVIDIA
6
NVDA
Apple
5
AAPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Axonex AI Group
AXNX
Mkt Cap6.16M
Axonics Modulation Technologies offers neuromodulation products that compete with Helius's technology in treating neurological disorders.
LivaNova
LIVN
Mkt Cap4.96B
LivaNova operates in the neuromodulation space, providing therapies for neurological disorders, which puts them in direct competition with Helius Medical Technologies.
Novartis
NVS
Mkt Cap307B
Novartis is a large pharmaceutical company with a broad portfolio that includes treatments for neurological conditions, competing on a larger scale with Helius's niche market.
Abbvie
ABBV
Mkt Cap514.92B
AbbVie has a strong presence in neuroscience, including R&D in neuromodulation, making it a competitor by offering alternative treatments for similar conditions.
Medtronic
MDT
Mkt Cap130.22B
Medtronic offers a wide range of neuromodulation devices, directly competing with Helius in providing medical technologies for neurological disorders.
Bristol-Myers Squibb
BMY
Mkt Cap127.02B
Bristol Myers Squibb, with its extensive portfolio in neuroscience, competes in developing treatments for conditions that Helius also aims to address with its technology.

About

Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities.
Show More
CEO
Dane Carl Andreeff
Employees
21
Country
Canada
ISIN
US42328V8761
WKN
000A41AV3

Listings

STU
DE
26H1.STU
MU
DE
26H1.MU
F
DE
26H1.F
XNAS
US
HSDT

0 Comments

Share your thoughts

FAQs

What is Solana stock price today?▼
The current price of HSDT is $1.83 USD — it has decreased by -4.95% in the past 24 hours. Watch Solana stock price performance more closely on the chart.
What is Solana stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Solana stocks are traded under the ticker HSDT.
Is Solana stock price growing?▼
HSDT stock has fallen by -11.41% compared to the previous week, the month change is a -23.64% fall, over the last year Solana has showed a -66.08% decrease.
What is Solana market cap?▼
Today Solana has the market capitalization of 118.82M
When is the next Solana earnings date?▼
Solana is going to release the next earnings report on March 11, 2027.
What is Solana revenue for the last year?▼
Solana revenue for the last year amounts to 6.02M USD.
What is Solana net income for the last year?▼
HSDT net income for the last year is -40.89M USD.
How many employees does Solana have?▼
As of November 10, 2026, the company has 21 employees.
In which sector is Solana located?▼
Solana operates in the Finance & Payments sector.
When did Solana complete a stock split?▼
The last stock split for Solana was on July 1, 2025 with a ratio of 1:50.
Where is Solana headquartered?▼
Solana is headquartered in PHILADELPHIA, Canada.